跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Khrizvitcee 500
Approved
STANDARD
Khrizvitcee 500
Reyoung Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3e156e282d1eb92e
Company
Reyoung Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
3e156e282d1eb92e
Drug Approval Philippines Name
Khrizvitcee 500
Product Name
Khrizvitcee 500
Registration Number
DR-XY47987
Brand Name
Khrizvitcee 500
Generic Name
500mg (equivalent to 200mg Ascorbic Acid and 300mg Sodium Ascorbate)
Dosage Form
Chewable Tablet
Dosage Strength
500 mg
Manufacturer
Reyoung Pharmaceutical Co., Ltd.
Importer
Khriz Pharma Trading Inc.
Distributor
Khriz Pharma Trading Inc.
Issuance Date
29 April 2022
Expiry Date
29 April 2027
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3e156e282d1eb92e
Type
Standard
Back to Philippines FDA Approvals
Khrizvitcee 500 - Philippines FDA Drug Approval Details